Majestic Research

What could you do with exclusive, real-time knowledge of the key metrics driving financial performance from individual companies to the entire pharmaceutical and biotech sector?  Majestic provides deep insight into all major prescription drugs. Our written prescription data from over 3,500 physicians across nine different specialties provides important promotional activity and prescription trends, and our proprietary oncology drug dispensing database, which we believe to be by far the largest in the market, provides granular treatment usage information on a patient-specific basis. We are able to give transparency in new drug launches and changes in prescription trends and usage resulting from major events that are not as apparent in pharmacy-level prescription data alone.

Data

Over 6,000 medical specialists across nine different networks: PCPs, cardiologists, endocrinologists, gastroenterologists, neurologists, psychiatrists, rheumatologists, urologists, and oncologists. Written Rx data includes patient diagnosis and demographics, new and renewal Rx share, product sampling rates, switch reason verbatims, and several other treatment-related variables. Dispensed Rx data includes date of administration and quantity of drug dispensed. Additionally, we collect data on how companies are marketing their drugs, what their share of physician attention is, and how their detailing translates into new written scripts.

Our proprietary data in the oncology space includes granular dispensing data from over 600 oncology clinics nationwide, representing over 2,500 oncology specialists, 80,000 cancer patients, and about 780,000 clinic visits per month. For most oncology drugs our analyses will include (among many other details) revenue models as well as off-label usage trends and, importantly, the ability to track patients over time.

Companies We Cover

ABII, AMGN, AMLN, BIIB, CELG, CEPH, DNA, IMCL, MOGN, MLNM, ONXX, OSIP, SEPR

Covered Indications: Acute Lymphatic Leukemia, Brain, Breast, Cervical, Chronic Lymphocytic Leukemia, Chronic Myeloid Leukemia, Colorectal, Kidney, Multiple Myeloma, Non-Hodgkin’s Lymphoma, Non-Small Cell Lung, Ovarian, Prostate, Small Cell Lung, and many others.

Other Covered Indications: Asthma, Bipolar/Schizophrenia, Cardiovascular Disease (Dyslipidemia/Hypertension), Depression, Diabetes, Erectile Dysfunction, Gastrointestinal Disorders, Insomnia, Multiple Sclerosis, Rheumatoid Arthritis, and many others.

Delivered Information

In our syndicated reports, we analyze drug data for:

• Market share for different drugs
• Drug switching activity
• Line of therapy (oncology drugs)
• Off-label usage
• Patient demographics
• Sampling rate
• Diagnosis breakdown for drugs approved for multiple indications